You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 9, 2025

Drug Price Trends for NDC 60505-4768


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 60505-4768

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
FLUPHENAZINE HCL 1MG TAB AvKare, LLC 60505-4768-01 100 54.14 0.54140 2023-08-07 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

60505-4768 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 60505-4768

Understanding the National Drug Code (NDC)

Before diving into the market analysis and price projections for the drug with the NDC 60505-4768, it is essential to understand what an NDC is. The National Drug Code (NDC) is a unique, 3-segment numeric identifier assigned to each medication listed under Section 510 of the U.S. Federal Food, Drug, and Cosmetic Act. This code helps in identifying the drug, its dosage form, and the package size[1].

Drug Identification

The NDC 60505-4768 is associated with a specific pharmaceutical product. To analyze the market and price projections, we need to identify the drug name and its characteristics.

Drug Name and Characteristics

While the specific drug name associated with NDC 60505-4768 is not provided in the sources, we can infer that it is likely a pharmaceutical product manufactured by a company with the labeler code 60505. This code is often associated with companies like Apotex Corp., as seen in other NDCs[5].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant changes that can impact the pricing and market dynamics of drugs.

Digital Transformation and Innovation

The life sciences industry is expected to see significant transformation in 2025, driven by digital advancements and scientific innovations. This includes the integration of technologies like gen AI and the increased use of data, which can boost operational efficiencies and drive breakthrough innovations[3].

Pricing and Access

Pricing and access to drugs are major concerns for the life sciences industry. Nearly half of the C-suite executives surveyed expect pricing and access to significantly affect their strategies in 2025. This trend is influenced by factors such as the patent cliff, where more than $300 billion in sales are at risk through 2030 due to expiring patents on high-revenue products[3].

Generic and Biosimilar Competition

Competition from generic drugs and biosimilars is another significant trend. 37% of respondents view this competition as a top trend, which can impact the pricing strategies of branded drugs[3].

Price Inflation Projections

For 2025, the overall drug price inflation rate is projected to be around 3.81%, according to Vizient's Pharmacy Market Outlook. This projection is influenced by factors such as the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[4].

Specific Price Projections for NDC 60505-4768

Since the specific drug associated with NDC 60505-4768 is not detailed in the sources, we cannot provide exact price projections. However, we can infer that the price will likely follow the general trends in the pharmaceutical industry.

Impact of Market Trends

  • Pricing and Access: If the drug is a high-revenue product nearing patent expiration, its price might be affected by the looming patent cliff and increased competition from generics or biosimilars.
  • Inflation Rate: The drug's price could increase by around 3.81% in line with the projected overall drug price inflation rate for 2025.
  • Market Competition: The presence of similar drugs or new indications for existing drugs could influence pricing strategies to remain competitive.

Operational and Budgetary Considerations

Healthcare providers need to prepare for the financial and operational impacts of new and existing drugs. For high-cost therapies, providers must organize cross-functionally to manage budgets, access treatments, and synchronize logistics for drug administration[4].

Example of Similar Drugs

To illustrate the potential pricing dynamics, let's consider a similar scenario with another drug. For instance, the NDC 51672-1387 associated with Dapsone 5% Gel shows price variations based on the unit of measure and vendor. The price per unit can range from $1.37 to $1.87, depending on the package size and date[2].

Key Takeaways

  • NDC Importance: The National Drug Code is crucial for identifying and billing pharmaceutical products.
  • Market Trends: The pharmaceutical industry is facing significant changes due to digital transformation, patent expirations, and competition from generics and biosimilars.
  • Price Inflation: The overall drug price inflation rate for 2025 is projected to be around 3.81%.
  • Operational Considerations: Healthcare providers must prepare for the financial and operational impacts of new and existing high-cost therapies.

FAQs

Q: What is the National Drug Code (NDC)? A: The National Drug Code (NDC) is a unique, 3-segment numeric identifier assigned to each medication listed under Section 510 of the U.S. Federal Food, Drug, and Cosmetic Act.

Q: How does the patent cliff affect drug pricing? A: The patent cliff, where high-revenue products lose exclusivity due to expiring patents, can lead to increased competition from generics and biosimilars, potentially reducing prices.

Q: What is the projected drug price inflation rate for 2025? A: The overall drug price inflation rate for 2025 is projected to be around 3.81%, according to Vizient's Pharmacy Market Outlook.

Q: How do high-cost cell and gene therapies impact healthcare providers? A: These therapies present budgetary, operational, and revenue obstacles, requiring healthcare providers to organize cross-functionally to manage them effectively.

Q: What role does digital transformation play in the pharmaceutical industry? A: Digital transformation, including the use of gen AI and data, is expected to boost operational efficiencies and drive breakthrough innovations in the pharmaceutical industry.

Sources

  1. Billing with National Drug Codes (NDCs) Frequently Asked Questions - Blue Cross Blue Shield of Illinois
  2. Latest drug prices and trends for NDC 51672-1387 - DrugPatentWatch
  3. 2025 life sciences outlook - Deloitte Insights
  4. Vizient projects drug price inflation at 3.81% - Vizient, Inc.
  5. CEFTRIAXONE SODIUM injection, powder, for solution - DailyMed

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.